Evaluation of the Birmingham IBS symptom questionnaire

BMC Gastroenterology

Volumn 8, Issue , 2008, Pages

  Roalfe, Andrea K ^a   Roberts, Lesley M ^a   Wilson, Sue ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BIRMINGHAM IBS SYMPTOM QUESTIONNAIRE; CLINICAL ASSESSMENT TOOL; CONSTIPATION; CRONBACH ALPHA COEFFICIENT; DIARRHEA; EFFECT SIZE; EXTERNAL VALIDITY; FEMALE; HEALTH STATUS; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PAIN; QUALITY OF LIFE INDEX; RELIABILITY; REPRODUCIBILITY; SCORING SYSTEM; SYMPTOMATOLOGY; TEST RETEST RELIABILITY; VALIDATION STUDY; ABDOMINAL PAIN; EVALUATION; FACTORIAL ANALYSIS; MIDDLE AGED; PATIENT ATTITUDE; QUESTIONNAIRE; STANDARD;

ABDOMINAL PAIN; ADULT; AGED; AGED, 80 AND OVER; CONSTIPATION; DIARRHEA; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 48949087081     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-8-30     Document Type: Article

References (42)

1. Agreus L Svardsudd K Nyren O Tibblin G Irritable bowel syndrome and dyspepsia in the general population: Overlap and lack of stability over time Gastroenterology 1995, 109:671-680 10.1016/0016-5085(95)90373-9 7657095
2. Thompson WG Heaton KW Functional bowel disorders in apparently healthy people Gastroenterology 1980, 79:283-288 7399231
3. Kennedy TM Jones RH Hungin AP O'Flanagan H Kelly P Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population Gut 1998, 43:770-774 1727355 9824603
4. Drossman DA Li Z Andruzzi E Temple RD Talley NJ Thompson WG et al U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact Dig Dis Sci 1993, 38:1569-1580 10.1007/BF01303162 8359066
5. Talley NJ Gabriel SE Harmsen WS Zinsmeister AR Evans RW Medical costs in community subjects with irritable bowel syndrome Gastroenterology 1995, 109:1736-1741 10.1016/0016-5085(95)90738-6 7498636
6. Hungin AP Whorwell PJ Tack J Mearin F The prevalence, patterns and impact of irritable bowel syndrome: An international survey of 40,000 subjects Aliment Pharmacol Ther 2003, 17:643-650 10.1046/ j.1365-2036.2003.01456.x 12641512
7. Jones R Lydeard S Irritable bowel syndrome in the general population BMJ 1992, 304:87-90 1880997 1737146
8. Thompson WG Heaton KW Smyth GT Smyth C Irritable bowel syndrome in general practice: Prevalence, characteristics, and referral Gut 2000, 46:78-82 1727778 10601059 10.1136/gut.46.1.78
9. Akehurst R Kaltenthaler E Treatment of irritable bowel syndrome: A review of randomised controlled trials Gut 2001, 48:272-282 1728206 11156653 10.1136/gut.48.2.272
10. Brandt LJ Bjorkman D Fennerty MB Locke GR Olden K Peterson W et al Systematic review on the management of irritable bowel syndrome in North America Am J Gastroenterol 2002, 97:S7-26 12425586
11. Tack J Fried M Houghton LA Spicak J Fisher G Systematic review: The efficacy of treatments for irritable bowel syndrome - A European perspective Alimentary Pharmacology and Therapeutics 2006, 24:183-205 10.1111/j.1365-2036.2006.02938.x
12. Jailwala J Imperiale TF Kroenke K Pharmacologic treatment of the irritable bowel syndrome: A systematic review of randomized, controlled trials Ann Intern Med 2000, 133:136-147 10896640
13. Bensoussan A Talley NJ Hing M Menzies R Guo A Ngu M Treatment of irritable bowel syndrome with Chinese herbal medicine: A randomized controlled trial JAMA 1998, 280:1585-1589 10.1001/jama.280.18.1585 9820260
14. Cook IJ Irvine EJ Campbell D Shannon S Reddy SN Collins SM Effect of dietary fiber on symptoms and rectosigmoid motility in patients with irritable bowel syndrome. A controlled, crossover study Gastroenterology 1990, 98:66-72 2152777
15. Klein KB Controlled treatment trials in the irritable bowel syndrome: A critique Gastroenterology 1988, 95:232-241 3286362
16. Veldhuyzen van Zanten SJ Talley NJ Bytzer P Klein KB Whorwell PJ Zinsmeister AR Design of treatment trials for functional gastrointestinal disorders Gut 1999, 45(Suppl 2):II69-77 10457048 1766689
17. Talley N Nyren O Drossman DA The irritable bowel syndrome: Toward optimal design of controlled treatment trials Gastroenterol Int 1993, 6:189-211
18. Drossman DA Corazziari E Delvaux M Spiller RC Talley NJ Thompson WG et al. Rome III. The functional gastrointestinal disorders Virginia, USA: Degnon Associates 3 2006.
19. Camilleri M Mayer EA Drossman DA Heath A Dukes GE McSorley D et al. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist Aliment Pharmacol Ther 1999, 13:1149-1159 10.1046/j.1365-2036.1999.00610.x 10468696
20. Mangel AW Hahn BA Heath AT Northcutt AR Kong S Dukes GE et al. Adequate relief as an endpoint in clinical trials in irritable bowel syndrome J Int Med Res 1998, 26:76-81 9602985
21. Jones RH Holtmann G Rodrigo L Ehsanullah RS Crompton PM Jacques LA et al. Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients Aliment Pharmacol Ther 1999, 13:1419-1427 10.1046/ j.1365-2036.1999.00678.x 10571597
22. Bijkerk CJ de Wit NJ Muris JW Jones RH Knottnerus JA Hoes AW Outcome measures in irritable bowel syndrome: Comparison of psychometric and methodological characteristics Am J Gastroenterol 2003, 98:122-127 10.1111/j.1572-0241.2003.07158.x 12526947
23. Camilleri M Mangel AW Fehnel SE Drossman DA Mayer EA Talley NJ Primary Endpoints for Irritable Bowel Syndrome Trials: A Review of Performance of Endpoints Clinical Gastroenterology and Hepatology 2007, 5:534-540 10.1016/j.cgh.2007.03.004
24. Wiklund IK Fullerton S Hawkey CJ Jones RH Longstreth GF Mayer EA et al. An irritable bowel syndrome-specific symptom questionnaire: Development and validation Scand J Gastroenterol 2003, 38:947-954 10.1080/ 00365520310004209 14531531
25. Bengtsson M Ohlsson B Ulander K Development and psychometric testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS) BMC Gastroenterol 2007, 7:16 1868742 17475020 10.1186/1471-230X-7-16
26. Patrick DL Drossman DA Frederick IO DiCesare J Puder KL Quality of life in persons with irritable bowel syndrome: Development and validation of a new measure Dig Dis Sci 1998, 43:400-411 10.1023/A:1018831127942 9512138
27. Drossman DA Patrick DL Whitehead WE Toner BB Diamant NE Hu Y et al. Further validation of the IBS-QOL: A disease-specific quality-of-life questionnaire Am J Gastroenterol 2000, 95:999-1007 10.1111/ j.1572-0241.2000.01941.x 10763950
28. Wilson S Roberts LM Roalfe A Bridge P Singh S Prevalence of irritable bowel syndrome: A community survey British Journal of General Practice 2004, 54:495-502 1324800 15239910
29. Drossman D Corazziari E Talley N Thompson W Whitehead W Rome II: The Functional Gastrointestinal Disorders: Diagnosis, pathophysiology and treatment: A multinational consensus McLean VA USA: Degnon Associates 2 2002.
30. Francis CY Morris J Whorwell PJ The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress Aliment Pharmacol Ther 1997, 11:395-402 10.1046/ j.1365-2036.1997.142318000.x 9146781
31. Drossman DA Li Z Toner BB Diamant NE Creed FH Thompson D et al. Functional bowel disorders. A multicenter comparison of health status and development of illness severity index Dig Dis Sci 1995, 40:986-995 10.1007/BF02064187 7729289
32. Fitzpatrick R Davey C Buxton MJ Jones DR Evaluating patient-based outcome measures for use in clinical trials Health Technol Assess 1998, 2(14)
33. Remington M Tyrer PJ Newson-Smith J Cicchetti DV Comparative reliability of categorical and analogue rating scales in the assessment of psychiatric symptomatology Psychol Med 1979, 9:765-770 515274
34. Cronbach LJ Coefficient alpha and the internal structure of tests Psychometrika 1951, 16:297-334 10.1007/BF02310555
35. Kirshner B Guyatt G A methodological framework for assessing health indices J Chronic Dis 1985, 38:27-36 10.1016/0021-9681(85)90005-0 3972947
36. Cohen J Statistical Power Analysis for the Behavioural Sciences New Jersey: LEA 1988.
37. Kazis LE Anderson JJ Meenan RF Effect sizes for interpreting changes in health status Med Care 1989, 27:S178-S189 10.1097/ 00005650-198903001-00015 2646488
38. Herz MJ Kahan E Zalevski S Aframian R Kuznitz D Reichman S Constipation:a different entity for patients and doctors Family Practice 1996, 13:156-159 10.1093/fampra/13.2.156 8732327
39. Helmstadter GC Principles of psychological measurement New York: Appleton-Century-Crofts 1964.
40. Streiner DL Norman GR Health measurement scales: A practical guide to their development and use Oxford: Oxford University Press 2 1995.
41. Roberts L Wilson S Singh S Roalfe A Greenfield S Gut-directed hypnotherapy for irritable bowel syndrome: Piloting a primary care-based randomised controlled trial Br J Gen Pract 2006, 56:115-121 1828217 16464325
42. Paterson C Measuring outcomes in primary care: A patient generated measure, MYMOP, compared with the SF-36 health survey BMJ 1996, 312:1016-1020